Viral Vectors and Plasmid DNA Manufacturing Market Size, Share, Growth Report 2032

• Chapter 1. Introduction
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Global Viral Vectors and Plasmid DNA Manufacturing market, 2016 - 2026 (USD Million)
  • 2.2. Global Viral Vectors and Plasmid DNA Manufacturing market: Snapshot
•  
• Chapter 3. Viral Vectors and Plasmid DNA Manufacturing Market - Industry Dynamics
  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Global Viral Vectors and Plasmid DNA Manufacturing market drivers: impact analysis
    • 3.2.2. Surge in global incidence of chronic diseases and increase in geriatric population
    • 3.2.3. Government initiatives & grants and an increase in investments by private companies on R&D activities
  • 3.3. Market Restraints
    • 3.3.1. Global Viral Vectors and Plasmid DNA Manufacturing market restraints: impact analysis
    • 3.3.2. Risk of mutagenesis and other impediments in gene therapy, and high costs associated with gene therapy
  • 3.4. Opportunities
    • 3.4.1. Untapped potential of developing countries provides lucrative opportunities to the market players
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. Threat from new entrants
    • 3.5.4. Threat from new substitutes
    • 3.5.5. Degree of competition
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. Market attractiveness analysis, by product type segment
    • 3.6.2. Market attractiveness analysis, by application segment
    • 3.6.3. Market attractiveness analysis, by End-User segment
    • 3.6.4. Market attractiveness analysis, by regional segment
•  
• Chapter 4. Global Viral Vectors and Plasmid DNA Manufacturing Market- Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global Viral Vectors and Plasmid DNA Manufacturing market: company market share, 2017
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New therapy launch
    • 4.2.3. Agreements, partnerships, collaborations and joint ventures
    • 4.2.4. Research and development and regional expansion
•  
• Chapter 5. Global Viral Vectors and Plasmid DNA Manufacturing Market- Product Type Segment Analysis
  • 5.1. Global Viral Vectors and Plasmid DNA Manufacturing market: product overview
    • 5.1.1. Global Viral Vectors and Plasmid DNA Manufacturing market revenue share, by product type, 2017 and 2026
  • 5.2. Viral Vectors
    • 5.2.1. Global Viral Vectors Manufacturing market, 2016 - 2026 (USD Million)
    • 5.2.2. Global Viral Vectors Manufacturing market for Retrovirus 2017
    • 5.2.3. Global Viral Vectors market for Lentiviruses 2017
    • 5.2.4. Global Viral Vectors Manufacturing market for Adenoviruses 2017
    • 5.2.5. Global Viral Vectors Manufacturing market for Adeno-Associated Viruses 2017
    • 5.2.6. Global Viral Vectors Manufacturing market for other Viruses 2017
  • 5.3. Plasmid
    • 5.3.1. Global Plasmid DNA Manufacturing market for Plasmid, 2016 - 2026 (USD Million)
    • 5.3.2. Global Plasmid DNA Manufacturing market for DNA Conjugative Plasmids 2017
    • 5.3.3. Global Plasmid DNA Manufacturing market for Non-Conjugative Plasmids 2017
•  
• Chapter 6. Global Viral Vectors and Plasmid DNA Manufacturing Market - Application Segment Analysis
  • 6.1. Global Viral Vectors and Plasmid DNA Manufacturing market: Application type overview
    • 6.1.1. Global Viral Vectors and Plasmid DNA Manufacturing market revenue share, by Application, 2017 and 2026
  • 6.2. Gene and Cancer Therapies
    • 6.2.1. Global Viral Vectors and Plasmid DNA Manufacturing market for Gene and Cancer Therapies, 2016 - 2026 (USD Million)
  • 6.3. Viral Infections
    • 6.3.1. Global Viral Vectors and Plasmid DNA Manufacturing market for Viral Infections, 2016 - 2026 (USD Million)
  • 6.4. Immunotherapy
    • 6.4.1. Global Viral Vectors and Plasmid DNA Manufacturing market for Immunotherapy,2016 - 2026 (USD Million)
  • 6.5. Formulation Development
    • 6.5.1. Global Viral Vectors and Plasmid DNA Manufacturing market for Formulation Development, 2016 - 2026 (USD Million)
  • 6.6. Other Applications
    • 6.6.1. Global Viral Vectors and Plasmid DNA Manufacturing market for other applications, 2016 - 2026 (USD Million)
•  
• Chapter 7. Global Viral Vectors and Plasmid DNA Manufacturing Market - End-User Segment Analysis
  • 7.1. Global Viral Vectors and Plasmid DNA Manufacturing market: End-User type overview
    • 7.1.1. Global Viral Vectors and Plasmid DNA Manufacturing market revenue share, by End-User, 2017 and 2026
  • 7.2. Biopharmaceutical Companies
    • 7.2.1. Global Viral Vectors and Plasmid DNA Manufacturing market for Biopharmaceutical Companies, 2016 - 2026 (USD Million)
  • 7.3. Research Institutes
    • 7.3.1. Global Viral Vectors and Plasmid DNA Manufacturing market for Research Institutes, 2016 - 2026 (USD Million)
  • 7.4. Other End-user
    • 7.4.1. Global Viral Vectors and Plasmid DNA Manufacturing market for Other End-user, 2016 - 2026 (USD Million)
•  
• Chapter 8. Global Viral Vectors and Plasmid DNA Manufacturing Market- Regional Segment Analysis
  • 8.1. Global Viral Vectors and Plasmid DNA Manufacturing market: regional overview
    • 8.1.1. Global Viral Vectors and Plasmid DNA Manufacturing market revenue share, by region, 2017 and 2026
  • 8.2. North America
    • 8.2.1. North America Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026 (USD Million)
    • 8.2.2. North America Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026 (USD Million)
    • 8.2.3. North America Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026 (USD Million)
    • 8.2.4. The U.S.
      • 8.2.4.1. The U.S. Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026(USD Million)
      • 8.2.4.2. The U.S. Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026(USD Million)
      • 8.2.4.3. The U.S. Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
    • 8.2.5. Rest of North America
      • 8.2.5.1. Rest of North America Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026(USD Million)
      • 8.2.5.2. Rest of North America Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026(USD Million)
      • 8.2.5.3. Rest of North America Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026(USD Million)
    • 8.3.2. Europe Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026(USD Million)
    • 8.3.3. Europe Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
    • 8.3.4. U.K.
      • 8.3.4.1. U.K. Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026 (USD Million)
      • 8.3.4.2. U.K. Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026(USD Million)
      • 8.3.4.3. U.K. Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
    • 8.3.5. Germany
      • 8.3.5.1. Germany Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026(USD Million)
      • 8.3.5.2. Germany Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026(USD Million)
      • 8.3.5.3. Germany Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
    • 8.3.6. France
      • 8.3.6.1. France Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026(USD Million)
      • 8.3.6.2. France Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026(USD Million)
      • 8.3.6.3. France Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
    • 8.3.7. Italy
      • 8.3.7.1. Italy Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026(USD Million)
      • 8.3.7.2. Italy Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026(USD Million)
      • 8.3.7.3. Italy Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
    • 8.3.8. Spain
      • 8.3.8.1. Spain Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026(USD Million)
      • 8.3.8.2. Spain Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026(USD Million)
      • 8.3.8.3. Spain Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
    • 8.3.9. Rest of Europe
      • 8.3.9.1. Rest of Europe Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026(USD Million)
      • 8.3.9.2. Rest of Europe Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026(USD Million)
      • 8.3.9.3. Rest of Europe Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026 (USD Million)
    • 8.4.2. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026(USD Million)
    • 8.4.3. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
    • 8.4.4. China
      • 8.4.4.1. ChinaViral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026(USD Million)
      • 8.4.4.2. China Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026(USD Million)
      • 8.4.4.3. China Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
    • 8.4.5. Japan
      • 8.4.5.1. Japan Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026(USD Million)
      • 8.4.5.2. Japan Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026(USD Million)
      • 8.4.5.3. Japan Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
    • 8.4.6. India
      • 8.4.6.1. India Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026 (USD Million)
      • 8.4.6.2. India Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026 (USD Million)
      • 8.4.6.3. India Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026 (USD Million)
    • 8.4.7. Southeast Asia
      • 8.4.7.1. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026(USD Million)
      • 8.4.7.2. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026(USD Million)
      • 8.4.7.3. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
    • 8.4.8. Rest of Asia Pacific
      • 8.4.8.1. Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026(USD Million)
      • 8.4.8.2. Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026(USD Million)
      • 8.4.8.3. Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026(USD Million)
    • 8.5.2. Latin America Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 - 2026(USD Million)
    • 8.5.3. Latin America Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
    • 8.5.4. Brazil
      • 8.5.4.1. Brazil Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026(USD Million)
      • 8.5.4.2. Brazil Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026(USD Million)
      • 8.5.4.3. Brazil Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
    • 8.5.5. Rest of Latin America
      • 8.5.5.1. Rest of Latin America Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026(USD Million)
      • 8.5.5.2. Rest of Latin America Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026(USD Million)
      • 8.5.5.3. Rest of Latin America Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
  • 8.6. The Middle East and Africa
    • 8.6.1. The Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026(USD Million)
    • 8.6.2. The Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 - 2026(USD Million)
    • 8.6.3. The Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
    • 8.6.4. GCC Countries
      • 8.6.4.1. GCC Countries Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026(USD Million)
      • 8.6.4.2. GCC Countries Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026(USD Million)
      • 8.6.4.3. GCC Countries Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
    • 8.6.5. Rest of the Middle East and Africa
      • 8.6.5.1. Rest of the Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 - 2026(USD Million)
      • 8.6.5.2. Rest of the Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing market revenue, by Application, 2016 - 2026(USD Million)
      • 8.6.5.3. Rest of the Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 - 2026(USD Million)
•  
• Chapter 9. Company Profile
  • 9.1. Vigene Biosciences Inc.
    • 9.1.1. Overview
    • 9.1.2. Financials
    • 9.1.3. Product portfolio
    • 9.1.4. Business strategy
    • 9.1.5. Recent developments
  • 9.2. Lonza
    • 9.2.1. Overview
    • 9.2.2. Financials
    • 9.2.3. Product portfolio
    • 9.2.4. Business strategy
    • 9.2.5. Recent developments
  • 9.3. FinVector Vision Therapies
    • 9.3.1. Overview
    • 9.3.2. Financials
    • 9.3.3. Product portfolio
    • 9.3.4. Business strategy
    • 9.3.5. Recent developments
  • 9.4. Kaneka Corporation (Eurogentec)
    • 9.4.1. Overview
    • 9.4.2. Financials
    • 9.4.3. Product portfolio
    • 9.4.4. Business strategy
    • 9.4.5. Recent developments
  • 9.5. XIFIN, Inc.
    • 9.5.1. Overview
    • 9.5.2. Financials
    • 9.5.3. Product portfolio
    • 9.5.4. Business strategy
    • 9.5.5. Recent developments
  • 9.6. VGXI, Inc.
    • 9.6.1. Overview
    • 9.6.2. Financials
    • 9.6.3. Product portfolio
    • 9.6.4. Business strategy
    • 9.6.5. Recent developments
  • 9.7. VIROVEK
    • 9.7.1. Overview
    • 9.7.2. Financials
    • 9.7.3. Product portfolio
    • 9.7.4. Business strategy
    • 9.7.5. Recent developments
  • 9.8. SIRION Biotech GmbH
    • 9.8.1. Overview
    • 9.8.2. Financials
    • 9.8.3. Product portfolio
    • 9.8.4. Business strategy
    • 9.8.5. Recent developments
  • 9.9. Cobra Biologics
    • 9.9.1. Overview
    • 9.9.2. Financials
    • 9.9.3. Product portfolio
    • 9.9.4. Business strategy
    • 9.9.5. Recent developments
  • 9.10. Novasep
    • 9.10.1. Overview
    • 9.10.2. Financials
    • 9.10.3. Product portfolio
    • 9.10.4. Business strategy
    • 9.10.5. Recent developments
  • 9.11. FUJIFILM Diosynth Biotechnologies Inc.
    • 9.11.1. Overview
    • 9.11.2. Financials
    • 9.11.3. Product portfolio
    • 9.11.4. Business strategy
    • 9.11.5. Recent developments
  • 9.12. Spark Therapeutics, Inc.
    • 9.12.1. Overview
    • 9.12.2. Financials
    • 9.12.3. Product portfolio
    • 9.12.4. Business strategy
    • 9.12.5. Recent developments
  • 9.13. Genzyme Corporation
    • 9.13.1. Overview
    • 9.13.2. Financials
    • 9.13.3. Product portfolio
    • 9.13.4. Business strategy
    • 9.13.5. Recent developments
  • 9.14. ALDEVRON
    • 9.14.1. Overview
    • 9.14.2. Financials
    • 9.14.3. Product portfolio
    • 9.14.4. Business strategy
    • 9.14.5. Recent developments
  • 9.15. Brammer Bio
    • 9.15.1. Overview
    • 9.15.2. Financials
    • 9.15.3. Product portfolio
    • 9.15.4. Business strategy
  • 9.16. General Electric Company (GE Healthcare)
    • 9.16.1. Overview
    • 9.16.2. Financials
    • 9.16.3. Product portfolio
    • 9.16.4. Business strategy

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Viral Vectors and Plasmid DNA Manufacturing market revenue, 2016 – 2026(USD Million) 
4. Porter’s Five Forces Analysis
5. Viral Vectors and Plasmid DNA Manufacturing market attractiveness analysis, by product type 
6. Viral Vectors and Plasmid DNA Manufacturing market attractiveness analysis, by application
7. Viral Vectors and Plasmid DNA Manufacturing market attractiveness analysis, by End-User
8. Viral Vectors and Plasmid DNA Manufacturing market: market attractiveness analysis, by region
9. Company market share analysis, 2017
10. Global Viral Vectors and Plasmid DNA Manufacturing market revenue share by product type, 2017 and 2026
11. Global Viral Vectors and Plasmid DNA Manufacturing market revenue share by Viral Vectors, 2017 and 2026
12. Global Viral Vectors and Plasmid DNA Manufacturing market revenue share by Plasmid, 2017 and 2026
13. Global Viral Vectors and Plasmid DNA Manufacturing market revenue share by Application, 2017 and 2026
14. Global Viral Vectors and Plasmid DNA Manufacturing market revenue share by Gene and Cancer Therapies, 2017 and 2026
15. Global Viral Vectors and Plasmid DNA Manufacturing market revenue share by Viral Infections, 2017 and 2026
16. Global Viral Vectors and Plasmid DNA Manufacturing market revenue share by Immunotherapy, 2017 and 2026
17. Global Viral Vectors and Plasmid DNA Manufacturing market revenue share by Formulation Development, 2017 and 2026
18. Global Viral Vectors and Plasmid DNA Manufacturing market revenue share by End-User, 2017 and 2026
19. Global Viral Vectors and Plasmid DNA Manufacturing market revenue share by Biopharmaceutical Companies, 2017 and 2026
20. Global Viral Vectors and Plasmid DNA Manufacturing market revenue share by Research Institutes, 2017 and 2026
21. Global Viral Vectors and Plasmid DNA Manufacturing market revenue share by Other End-users, 2017 and 2026

Table Of Tables

List of Tables

1. Viral Vectors and Plasmid DNA Manufacturing market: Market Snapshot                                                                                   
2. Drivers of global Viral Vectors and Plasmid DNA Manufacturing market: impact analysis 
3. Restraints of global Viral Vectors and Plasmid DNA Manufacturing market: impact analysis
4. North America Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
5. North America Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
6. North America Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
7. The U.S. Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
8. The U.S. Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
9. The U.S. Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
10. Rest of North America Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
11. Rest of North America Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
12. Rest of North America Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
13. Europe Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
14. Europe Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
15. Europe Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
16. UK Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
17. UK Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
18. UK Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
19. Germany Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
20. Germany Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
21. Germany Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
22. France Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
23. France Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
24. France Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
25. Italy Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
26. Italy Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
27. Italy Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
28. Spain Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
29. Spain Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
30. Spain Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
31. Rest of Europe Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
32. Rest of Europe Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
33. Rest of Europe Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
34. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
35. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
36. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
37. China Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
38. China Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
39. China Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
40. Japan Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
41. Japan Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
42. Japan Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
43. India Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
44. India Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
45. India Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
46. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
47. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
48. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
49. Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
50. Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
51. Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
52. Latin America Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
53. Latin America Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
54. Latin America Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
55. Brazil Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
56. Brazil Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
57. Brazil Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
58. Rest of Latin America Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
59. Rest of Latin America Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
60. Rest of Latin America Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
61. The Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
62. The Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
63. The Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
64. GCC Countries Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
65. GCC Countries Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
66. GCC Countries Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
67. South Africa Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
68. South Africa Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
69. South Africa Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)
70. Rest of the Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing market revenue, by product type, 2016 – 2026(USD Million)
71. Rest of the Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing market revenue, by application, 2016 – 2026(USD Million)
72. Rest of the Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing market revenue, by End-User, 2016 – 2026(USD Million)